Live Analyst Rating Changes 24522 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Mark Marcon
BAIRD

Mark Marcon

Robert W. Baird
Wall Street Analyst
★★★★★
#22
on 13Foresight · ranked by our own returns
87%
Success Rate
+26.0%
Average Return
26 of 30 calls profitable · +19.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 87% of Mark Marcon's ratings turned a profit when each position was held for 1 year — averaging +26.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

21 Buy 11 Hold 0 Sell
Mark's Stock Coverage 18 ratings · 2026-08-14
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AMN
AMN Healthcare Services
 Aug 07, 2026 HOLD Buy
+29.9% avg upside
14 analysts
$36.00
4.47% Upside
 -3.6% ·
PAYC
Paycom
 Aug 06, 2026 BUY Buy
+8.0% avg upside
32 analysts
$245.00
9.65% Upside
 +1.6% ·
PCTY
Paylocity
 Aug 05, 2026 BUY Strong Buy
+14.6% avg upside
30 analysts
$201.00
31.66% Upside
 +0.5% ·
TBI
Trueblue
 Aug 05, 2026 BUY Strong Buy
+88.6% avg upside
5 analysts
$9.50
6.30% Downside
 +2.4% ·
NSP
Insperity
 Jul 31, 2026 HOLD Hold
+4.2% avg upside
6 analysts
$56.00
4.05% Upside
 +2.5% ·
WTW
Willis Towers Watson
 Jul 31, 2026 BUY Strong Buy
+5.1% avg upside
28 analysts
$385.00
15.19% Upside
 -1.0% ·
EFOR
Everforth
 Jul 30, 2026 HOLD Buy
+30.7% avg upside
14 analysts
$33.00
1.34% Downside
 +16.9% ·
ADP
Automatic Data Processing
 Jul 30, 2026 HOLD Hold
-9.8% avg upside
28 analysts
$305.00
10.47% Upside
 +2.7% ·
KFRC
Kforce
 Jul 28, 2026 BUY Buy
-2.0% avg upside
9 analysts
$63.00
4.26% Upside
 +3.4% ·
MAN
ManpowerGroup
 Jul 17, 2026 BUY Buy
+22.0% avg upside
17 analysts
$72.00
21.79% Upside
 +7.4% ·
KFY
Korn Ferry
 Jun 24, 2026 BUY Strong Buy
-2.1% avg upside
9 analysts
$85.00
0.10% Upside
 +19.6% ·
ANDG
Andersen Group, Inc. Class A
 May 13, 2026 BUY Strong Buy
+1.5% avg upside
7 analysts
$44.00
8.87% Downside
 +35.3% ·
PAYX
Paychex
 Mar 26, 2026 HOLD Hold
-14.8% avg upside
27 analysts
$125.00
0.27% Downside
 +32.5% ·
WDAY
Workday
 Feb 24, 2026 BUY Buy
-0.3% avg upside
54 analysts
$190.00
8.05% Downside
 +53.4% ·
RHI
Robert Half
 Jan 30, 2026 BUY Buy
+7.0% avg upside
15 analysts
$50.00
14.26% Upside
 +29.4% ·
HQY
Healthequity
 Jun 03, 2024 BUY Strong Buy
+8.0% avg upside
20 analysts
$104.00
1.45% Downside
 +27.8% ·
RGP
Resources Connection
 Apr 03, 2024 HOLD Hold
+306.2% avg upside
11 analysts
$13.00
208.03% Upside
 -54.0% ·
NFLX
Netflix
 Feb 28, 2014 HOLD Buy
+119.4% avg upside
79 analysts
 — +6.4% ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Mark Marcon — Frequently Asked Questions
How accurate are Mark Marcon's stock ratings?
Based on the calls 13Foresight could measure, about 83% of Mark's ratings were profitable over a one-year hold, with an average return of +26.3% per rating, or +19.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Mark ranked on 13Foresight?
Mark Marcon is currently ranked #22 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Mark cover?
Mark most recently has ratings on AMN, PAYC, PCTY, TBI, NSP, WTW, EFOR, ADP, KFRC, MAN, KFY, ANDG and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.